Clinical trial
Safety Profile of Booster IndoVac COVID-19 Vaccination in Healthy Populations Aged 18 Years and Above
NCT06690502 is registered in ClinicalTrials.gov with PT Bio Farma as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Safety Profile of Booster IndoVac COVID-19 Vaccination in Healthy Populations Aged 18 Years and Above
- Lead sponsor
- PT Bio Farma
- Phase
- Observational
- Overall status
- Completed
- Start date
- December 18, 2023
- Completion date
- June 7, 2024
- Enrollment
- 1,208 (actual)
- Sites
- 28
Conditions
As the registry lists them; a condition with its own page is linked.